Cocrystal Pharma (COCP) vs SeaStar Medical (ICU)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Cocrystal Pharma (COCP) has outperformed SeaStar Medical (ICU) over the past year, losing 14.4% versus a loss of 47.0%. Over five years, COCP leads with a -90.5% price change compared with -99.9% for ICU. Cocrystal Pharma is the larger company by market cap ($20.6 million vs $18.4 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | COCP | ICU |
|---|---|---|
| Share price | $1.07 | $3.49 |
| Market cap | $20.61M | $18.36M |
| 1-day change | 0.00% | -6.18% |
| YTD return | +9.18% | +45.42% |
| 1-year return | -14.40% | -47.04% |
| 5-year return | -90.51% | -99.86% |
| EPS (TTM) | $-0.76 | $-2.97 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $2.03 | $7.35 |
| 52-week low | $0.76 | $2.07 |
| Distance from 52-week high | -47.29% | -52.52% |
| Analyst consensus | none | none |
| Avg. price target upside | +741.12% | +186.53% |
| Average volume | 56.00K | 99.80K |
| Shares outstanding | 19.26M | 5.26M |
| Employees | 10 | 18 |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- COCP has outperformed ICU by 32.6 percentage points over the past year.
About Cocrystal Pharma
COCP stock →Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases in the United States. The company employs structure-based technologies to create antiviral drugs including influenza virus, norovirus, coronaviruses, such as SARS-CoV-2 and MERS-CoV, as well as respiratory virus infections, and hepatitis C virus (HCV) infections.
Healthcare · Biotechnology · 10 employees
About SeaStar Medical
ICU stock →SeaStar Medical Holding Corporation, a commercial-stage healthcare company, develops a proprietary platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers the selective cytopheretic device (SCD), which is a disease-modifying device that neutralizes over-active immune cells and stops the cytokine storm that yields destructive hyperinflammation; and QUELIMMUNE, an SCD therapy for pediatric patients with acute kidney injury (AKI) due to sepsis.
Healthcare · Biotechnology · 18 employees
COCP vs ICU FAQ
Which is bigger, Cocrystal Pharma or SeaStar Medical?
Cocrystal Pharma (COCP) is larger, with a market capitalization of $20.61M compared with $18.36M for SeaStar Medical (ICU).
Which stock has performed better over the past year, COCP or ICU?
COCP returned -14.40% over the past 12 months, compared with -47.04% for ICU (price return, excluding dividends). Past performance does not predict future results.
Are Cocrystal Pharma and SeaStar Medical in the same industry?
Yes. Both are classified in the Biotechnology industry within the Healthcare sector.